Decheng Capital Global Life Sciences Fund IV, L.P. is 10% Owner at Aardvark Therapeutics, Inc. (AARD). They have made 1 open-market trade across 1 company since 2025, most recently 2025-02-14.
CIK 0001834150
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10.0M since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AARD | 2,333,887 | $8.8M |
Shares reported on the most recent Form 4, priced at the 2025-02-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AARD | BUY | 2025-02-14 | 2025-02-19 | $16.00 | $10.0M | -19.9% | -37.6% | -30.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.